糖基化终产物对视网膜VEGF及Flk-1表达的影响

被引:0
作者
伍大洋
机构
[1] 中国医科大学
关键词
糖基化终产物; 糖尿病视网膜病变; 血管内皮生长因子; 血管内皮生长因子受体;
D O I
暂无
年度学位
2008
学位类型
硕士
导师
摘要
目的 糖尿病视网膜病变(diabetic retinopathy,DR)是常见致盲眼病之一,其发生和进展与血糖水平、疾病病程、遗传及控制情况等多种因素有关。对于DR的发病机制,目前的研究主要集中在高血糖、多元醇代谢异常、蛋白质非酶糖化、血流动力学异常、细胞因子等方面。长期高血糖引起机体蛋白质非酶糖化所形成的糖基化终产物(AGEs)大量堆积是导致DR发生的主要原因。DR的实质是进展性的微血管病变,新生血管形成是其特征性的病理改变。在血管新生的过程中,血管内皮生长因子(VEGF)通过其受体起重要作用。本实验通过观察AGEs对健康大鼠视网膜VEGF及其受体(flk-1)表达的影响,探讨AGEs与VEGF及flk-1之间内在关系,以及AGEs在DR发病过程中的重要作用。 方法 1、体外制备AGEs,BSA50g/l和D-glucose 0.5mol/1溶于0.2mol/1 PH 7.4 PBS中。对照组不含D-glucose,余同。37℃温育三个月。三个月后取出,透析。经荧光分光光度法鉴定。 2、20只SD大鼠随机分为AGEs实验组和BSA对照组,每组10只。分别于鼠尾静脉以40mg/kg·d的剂量注射AGEs和BSA,每日1次,连续2周。 3、二周后处死大鼠,视网膜行免疫组织化学染色,计数视网膜VEGF及flk-1的表达。 结果 1、体外孵育产物经荧光分光光度法鉴定,实验组产物荧光值为52.67U/mg,对照组产物荧光值为5.65U/mg。 2、大鼠血糖平均值,AGEs组[(5.153±0.148)mmol/1]与BSA组[(5.130±0.112)mmol/1,P>0.05]无统计学差别。 3、视网膜节细胞层和内核层出现的棕黄色染色的VEGF阳性细胞数,AGEs组[(31.277±6.963)个]较BSA对照组[(20.986±5.838)个,P<0.05]多。 4、视网膜节细胞层和内核层出现的淡黄色染色的flk-1阳性细胞数,AGEs组[(2.175±0.677)个]较BSA对照组[(1.756±0.493)个,P<0.05]多。 结论 1、AGEs可作为独立危险因素参与DR的损害过程。 2、AGEs与VEGF及flk-1正相关,它们可能共同参与DR的发展。
引用
收藏
页数:34
共 19 条
[1]
The role of advanced glycation end products in progression and complications of diabetes [J].
Goh, Su-Yen ;
Cooper, Mark E. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) :1143-1152
[2]
Advanced glycation end products - Sparking the development of diabetic vascular injury [J].
Goldin, Alison ;
Beckman, Joshua A. ;
Schmidt, Ann Marie ;
Creager, Mark A. .
CIRCULATION, 2006, 114 (06) :597-605
[3]
Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide [J].
Mamputu, JC ;
Renier, G .
DIABETES OBESITY & METABOLISM, 2004, 6 (02) :95-103
[4]
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders [J].
Hudson, BI ;
Bucciarelli, LG ;
Wendt, T ;
Sakaguchi, T ;
Lalla, E ;
Qu, W ;
Lu, Y ;
Lee, L ;
Stern, DM ;
Naka, Y ;
Ramasamy, R ;
Yan, SD ;
Yan, SF ;
D'Agati, V ;
Schmidt, AM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 419 (01) :80-88
[5]
Alteration of the intracellular pH and apoptosis induction in a retinal cell line by the AGE-inducing agent glyoxal [J].
Reber, F ;
Kasper, M ;
Siegner, A ;
Kniep, E ;
Seigel, G ;
Funk, RHW .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (12) :1022-1032
[6]
Advanced glycation end products increase; through a protein kinase C-dependent pathway; vascular endothelial growth factor expression in retinal endothelial cells.[J].Jean-Claude Mamputu;Geneviève Renier.Journal of Diabetes and Its Complications.2002, 4
[7]
Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: A possible role in ocular neovascularization [J].
Swamy-Mruthinti, S ;
Miriam, KC ;
Kumar, SK ;
Biswas, J ;
Ramakrishnan, S ;
Nagaraj, RH ;
Sulochana, KN .
CURRENT EYE RESEARCH, 2002, 25 (03) :139-145
[8]
Advanced glycation end-products: a review [J].
Singh, R ;
Barden, A ;
Mori, T ;
Beilin, L .
DIABETOLOGIA, 2001, 44 (02) :129-146
[9]
Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes [J].
Aso, Y ;
Inukai, T ;
Tayama, K ;
Takemura, Y .
ACTA DIABETOLOGICA, 2000, 37 (02) :87-92
[10]
Advanced Glycation End Products Induce Blood–Retinal Barrier Dysfunction in Normoglycemic Rats.[J].Alan W. Stitt;Tisha Bhaduri;C.B.Tara McMullen;Thomas A. Gardiner;Desmond B. Archer.Molecular Cell Biology Research Communications.2000, 6